Announcements

Executive Vice-Chairman and Director Raymond R. Quirk of Fidelity National Financial, Inc. filed a Form 4 on November 9, 2026, disclosing a disposition of common stock on November 6, 2026.

Fidelity National Financial, Inc. EVP and Chief Financial Officer Anthony Park filed a Form 4 on November 9, 2026, disclosing a disposition of common stock on November 6, 2026.

Aspen Neuroscience, Inc. (NASDAQ:ASPE) Executive Chair Hasnain Faheem filed a statement of changes in beneficial ownership on November 9, 2026, reporting the acquisition of 321,672 shares of common stock on November 5, 2026, through a fully vested restricted stock unit award.

A Schedule 13G was filed on November 9, 2026, by Frazier Life Sciences X, L.P. and related reporting persons, disclosing beneficial ownership of 1,674,321 shares of common stock in Aspen Neuroscience, Inc. following the company's initial public offering.

Peter T. Sadowski, Executive Vice President and Chief Legal Officer of Fidelity National Financial, Inc., filed a Form 4 on November 9, 2026, reporting a disposition of common stock on November 6, 2026.

A group of ARCH Venture-affiliated entities and individuals filed a Schedule 13D with the SEC on November 9, 2026, disclosing a combined beneficial ownership position in Aspen Neuroscience, Inc. common stock as of a triggering event dated November 2, 2026.

Director Glenn Lurie of Avis Budget Group, Inc. filed a Form 4 on November 9, 2026, disclosing three separate sales of common stock totaling 6,101 shares on November 6, 2026.